End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.55 CNY | -0.08% | -1.47% | +7.26% |
Business Summary
Number of employees: 9,005
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Chemical
55.4
%
| 7,224 | 59.9 % | 7,000 | 55.4 % | -3.11% |
APIs and Intermediates
24.8
%
| 2,909 | 24.1 % | 3,138 | 24.8 % | +7.89% |
Chinese Medicine Preparation
9.9
%
| 1,071 | 8.9 % | 1,254 | 9.9 % | +17.07% |
Diagnostic Reagents and Equipment
5.7
%
| 724 | 6.0 % | 724 | 5.7 % | -0.06% |
Biological
3.2
%
| - | - | 408 | 3.2 % | - |
Other Business
0.3
%
| 53 | 0.4 % | 42 | 0.3 % | -21.16% |
Sales Materials
0.3
%
| 46 | 0.4 % | 40 | 0.3 % | -11.62% |
Processing
0.1
%
| 5 | 0.0 % | 9 | 0.1 % | +70.82% |
Power Supply
0.1
%
| 8 | 0.1 % | 8 | 0.1 % | +0.36% |
Rental
0.1
%
| 5 | 0.0 % | 7 | 0.1 % | +49.48% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
87.5
%
| 10,389 | 87.1 % | 10,959 | 87.5 % | +5.48% |
Overseas
12.5
%
| 1,539 | 12.9 % | 1,565 | 12.5 % | +1.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yang Gang Tang
PSD | President | 55 | 18-07-16 |
Yan Xia Si
DFI | Director of Finance/CFO | 56 | 93-03-31 |
Maolin Wang
CHM | Chairman | 59 | 00-12-31 |
Bao Guo Zhu
CHM | Chairman | 62 | 01-12-31 |
Guo Xiang Xu
BRD | Director/Board Member | 61 | 07-02-28 |
De Sheng Tao
BRD | Director/Board Member | 60 | 84-12-31 |
De Long Ye
IRC | Investor Relations Contact | - | - |
Yu Xuan Huang
PRN | Corporate Officer/Principal | 57 | 18-10-24 |
Dai Hong Yang
PRN | Corporate Officer/Principal | 58 | 96-12-31 |
Liang Yang
SEC | Corporate Secretary | 41 | 11-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bao Guo Zhu
CHM | Chairman | 62 | 01-12-31 |
Qing Feng Qiu
BRD | Director/Board Member | 53 | 07-03-31 |
Maolin Wang
CHM | Chairman | 59 | 00-12-31 |
De Sheng Tao
BRD | Director/Board Member | 60 | 84-12-31 |
Guo Xiang Xu
BRD | Director/Board Member | 61 | 07-02-28 |
Dai Hong Yang
PRN | Corporate Officer/Principal | 58 | 96-12-31 |
Yin Tang
BRD | Director/Board Member | 49 | 15-12-28 |
Yang Gang Tang
PSD | President | 55 | 18-07-16 |
Li Jie Cui
BRD | Director/Board Member | 48 | 21-07-28 |
Kam Wa Wong
BRD | Director/Board Member | 53 | 19-10-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 309,831,217 | 0 | 0 | 37.91 % |
Stock B | 1 | 628,247,779 | 355,635,814 ( 56.61 %) | 11,614,548 ( 1.849 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
5,829,048 | 0.96% | 31,190,361 $ |
Company contact information
Livzon Pharmaceutical Group, Inc.
Headquarters Building 38 Chuangye North Road
519090, Zhuhai
+86 75 6813 5888
http://www.livzon.com.cnSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.26% | 4.25B | |
+35.02% | 701B | |
+26.24% | 571B | |
+1.00% | 381B | |
+20.90% | 334B | |
+16.93% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-2.80% | 157B |
- Stock
- Equities
- Stock Livzon Pharmaceutical Group Inc. - Shenzhen S.E.
- Company Livzon Pharmaceutical Group Inc.